|
Market Closed -
Bombay S.E.
06:02:27 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 196.40 INR | -3.84% |
|
-3.23% | +138.78% |
| 09-11 | IOL Chemicals and Pharmaceuticals Limited - Special Call | |
| 08-13 | IOL Chemicals and Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 13, 2026 |
Company Valuation: IOL Chemicals and Pharmaceuticals Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 16,608 | 21,222 | 17,964 | 21,354 | 57,649 | - |
| Change | - | 27.78% | -15.35% | 18.87% | 169.97% | - |
| Enterprise Value (EV) | 16,608 | 21,222 | 17,964 | 21,354 | 57,649 | 57,649 |
| Change | - | 27.78% | -15.35% | 18.87% | 169.97% | 0% |
| P/E | 11.9x | 15.8x | 17.8x | 15.5x | 26.2x | 18.9x |
| PBR | 1.1x | 1.32x | 1.06x | 1.19x | 2.94x | 2.65x |
| PEG | - | -4.68x | -0.7x | 0.4x | 0.4x | 0.5x |
| Capitalization / Revenue | 0.75x | 1x | 0.86x | 0.92x | 2.1x | 1.83x |
| EV / Revenue | 0x | 0x | 0x | 0x | 2.1x | 1.83x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 15.8x | 11.9x |
| EV / EBIT | 0x | 0x | 0x | 0x | 18.5x | 13.4x |
| EV / FCF | -0x | 0x | -0x | 0x | 20.8x | 31.8x |
| FCF Yield | -5.39% | 0.78% | -1.94% | 1.94% | 4.81% | 3.15% |
| Dividend per Share 2 | 0.8 | 1 | 4 | - | - | - |
| Rate of return | 1.41% | 1.38% | 6.54% | - | - | - |
| EPS 2 | 4.74 | 4.58 | 3.44 | 4.69 | 7.5 | 10.4 |
| Distribution rate | 16.9% | 21.8% | 116% | - | - | - |
| Net sales 1 | 22,171 | 21,328 | 20,792 | 23,191 | 27,424 | 31,525 |
| EBITDA 1 | 2,257 | 2,306 | 2,023 | 2,690 | 3,647 | 4,860 |
| EBIT 1 | 2,051 | 1,677 | 1,303 | 1,887 | 3,123 | 4,295 |
| Net income 1 | 1,391 | 1,344 | 1,011 | 1,376 | 2,198 | 3,060 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 56.58 | 72.30 | 61.20 | 72.75 | 196.40 | 196.40 |
| Nbr of stocks (in thousands) | 293,528 | 293,528 | 293,528 | 293,528 | 293,528 | - |
| Announcement Date | 4/28/23 | 5/14/24 | 5/16/25 | 5/20/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 27.23x | - | - | - | 626M | ||
| 33.65x | 12.19x | 24.78x | 0.59% | 1,055B | ||
| 30.17x | 6.71x | 18.78x | 1.98% | 654B | ||
| 33.43x | 7.82x | 16.17x | 2.59% | 467B | ||
| 19.59x | 4.78x | 11.84x | 2.78% | 348B | ||
| 20.4x | 5.31x | 13.17x | 3.01% | 275B | ||
| 21.19x | 4.39x | 12.5x | 2.01% | 258B | ||
| 26.19x | 6.82x | 12.15x | 2.43% | 224B | ||
| -45.65x | 6.64x | 25.94x | 2.18% | 187B | ||
| 11.33x | 4.13x | 8.58x | 4.44% | 171B | ||
| Average | 17.75x | 6.53x | 15.99x | 2.45% | 363.9B | |
| Weighted average by Cap. | 24.18x | 7.87x | 18.13x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IOLCP Stock
- Valuation IOL Chemicals and Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















